Clinical Trials Browser

Phase 2 × Parturition × 90 days × Clear all

NCT06026371 2026-01-12

Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation

Phase 2 Active not recruiting

Acute Graft Versus Host Disease

NCT04729322 2025-12-23

Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms